Evidence of higher oxidative status in depression and anxiety

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Grases, G ^a,b   Colom, M A ^a   Fernandez, R A ^c   Costa Bauza A ^c   Grases, F ^c  

^a Psychology and Neurology Center (CLONUS)   (Spain)

^b UNIVERSIDAD PONTIFICIA COMILLAS   (Spain)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; BODY FLUIDS; SECONDARY BATTERIES; SURVEYS;

ANTIOXIDANT CAPACITY; ANXIETY STATE; BECK DEPRESSION INVENTORIES; OXIDATIVE STATUS; PLATINUM ELECTRODES; REDOX POTENTIALS; SIMPLE METHOD; STANDARD CONDITIONS;

REDOX REACTIONS;

1,10 FENANTROLINE; ANTIOXIDANT; DYE; FERRIC ION; MERCUROUS CHLORIDE; PLATINUM; UNCLASSIFIED DRUG; OXIDIZING AGENT;

ADULT; AGED; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DEPRESSION; ELECTRODE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; STATE TRAIT ANXIETY INVENTORY; URINALYSIS; URINE; METABOLISM; MIDDLE AGED; PATHOLOGY; QUESTIONNAIRE; STATISTICAL MODEL;

ADULT; AGED; ANTIOXIDANTS; ANXIETY; DEPRESSION; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; QUESTIONNAIRES;

EID: 84901277100     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/430216     Document Type: Article

References (26)

1. McCord J. M., Human disease, free radicals, and the oxidant/antioxidant balance. Clinical Biochemistry 1993 26 5 351 357 2-s2.0-0027363967 10.1016/0009-9120(93)90111-I (Pubitemid 23326737)
2. Mates J. M., Perez-Gomez C., de Castro I. N., Antioxydant enzymes and human diseases. Clinical Biochemistry 1999 32 8 595 603 10.1016/S0009-9120(99) 00075-2 (Pubitemid 30039087)
3. Seifried H. E., Anderson D. E., Fisher E. I., Milner J. A., A review of the interaction among dietary antioxidants and reactive oxygen species. Journal of Nutritional Biochemistry 2007 18 9 567 579 2-s2.0-34547666796 10.1016/j.jnutbio.2006.10.007 (Pubitemid 47214661)
4. Gutteridge J. M. C., Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clinical Chemistry 1995 41 12 1819 1828 2-s2.0-0028792111
5. Kovacic P., Somanathan R., Redox processes in neurodegenerative disease involving reactive oxygen species. Current Neuropharmacology 2012 10 4 289 302 10.2174/157015912804499429
6. Wahlqvist M. L., Antioxidant relevance to human health. Asia Pacific Journal of Clinical Nutrition 2013 22 2 171 176
7. Bouayed J., Rammal H., Soulimani R., Oxidative stress and anxiety relationship and cellular pathways. Oxidative Medicine and Cellular Longevity 2009 2 2 63 67 2-s2.0-63449091380
8. Hovatta I., Juhila J., Donner J., Oxidative stress in anxiety and comorbid disorders. Neuroscience Research 2010 68 4 261 275 2-s2.0-78149470797 10.1016/j.neures.2010.08.007
9. Halliwell B., Oxidative stress and neurodegeneration: where are we now? Journal of Neurochemistry 2006 97 6 1634 1658 2-s2.0-33745013111 10.1111/j.1471-4159.2006.03907.x (Pubitemid 43873658)
10. Berk M., Ng F., Dean O., Dodd S., Bush A. I., Glutathione: a novel treatment target in psychiatry. Trends in Pharmacological Sciences 2008 29 7 346 351 2-s2.0-45849098291 10.1016/j.tips.2008.05.001
11. Maes M., Galecki P., Chang Y. S., Berk M., A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 3 676 692 2-s2.0-79954568978 10.1016/j.pnpbp.2010.05.004
12. Scapagnini G., Davinelli S., Drago F., de Lorenzo A., Oriani G., Antioxidants as antidepressants: fact or fiction? CNS Drugs 2012 26 6 477 490 10.2165/11633190-000000000-00000
13. Erel O., A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical Biochemistry 2004 37 4 277 285 2-s2.0-1542316295 10.1016/j.clinbiochem. 2003.11.015 (Pubitemid 38314881)
14. Wu L. L., Chiou C. C., Chang P. Y., Wu J. T., Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clinica Chimica Acta 2004 339 1-2 1 9 2-s2.0-0345735389 10.1016/j.cccn.2003.09.010 (Pubitemid 37542453)
15. Valavanidis A., Vlachogianni T., Fiotakis C., 8-hydroxy-2′- deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. Journal of Environmental Science and Health C: Environmental Carcinogenesis & Ecotoxicology Reviews 2009 27 2 120 139 2-s2.0-66149088854
16. Forlenza M. J., Miller G. E., Increased serum levels of 8-hydroxy-2′-deoxyguanosinein clinicaldepression. Psychosomatic Medicine 2006 68 1 1 7 10.1097/01.psy.0000195780.37277.2a (Pubitemid 43803209)
17. Wei Y. C., Zhou F. L., He D. L., Bai J. R., Hui L. Y., Wang X. Y., Nan K. J., The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma. Journal of Psychosomatic Research 2009 66 3 259 266 2-s2.0-59849113945 10.1016/j.jpsychores.2008.09.001
18. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E., Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuroendocrinology Letters 2009 30 6 715 722 2-s2.0-77649266722
19. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E., Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. Journal of Affective Disorders 2010 125 1-3 287 294 2-s2.0-77955556964 10.1016/j.jad.2009.12.014
20. Rammal H., Bouayed J., Younos C., Soulimani R., The impact of high anxiety level on the oxidative status of mouse peripheral blood lymphocytes, granulocytes and monocytes. European Journal of Pharmacology 2008 589 1-3 173 175 2-s2.0-47749091233 10.1016/j.ejphar.2008.06.053
21. Lucca G., Comim C. M., Valvassori S. S., Réus G. Z., Vuolo F., Petronilho F., Gavioli E. C., Dal-Pizzol F., Quevedo J., Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. Journal of Psychiatric Research 2009 43 9 864 869 2-s2.0-67349156772 10.1016/j.jpsychires.2008.11.002
22. Stafford L., Berk M., The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? Journal of Clinical Psychiatry 2011 72 9 1229 1235 2-s2.0-80053005570 10.4088/JCP.09m05825blu
23. Spielberger C. D., Gorsuch R. L., Lushene R. E., State-Trait Anxiety Inventory Questionnaire 1968 Palo Alto, Calif, USA Consulting Psychologists Press. Validated by Department I+D TEA Editions S.A., Madrid, Spain, 1982
24. Beck A. T., Rush A. J., Shaw B. F., Emery G., Beck Depresión Inventory, Cognitive Therapy of Depression 1979 New York, NY, USA Guilford Press. Trad. esp. en Bilbao: Desclée de Brouwer, 1983
25. Benzie I. F. F., Strain J. J., The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Analytical Biochemistry 1996 239 1 70 76 2-s2.0-0030586361 10.1006/abio.1996.0292 (Pubitemid 26256285)
26. Hayes W. A., Mills D. S., Neville R. F., Kiddie J., Collins L. M., Determination of the molar extinction coefficient for the ferric reducing/antioxidant power assay. Analytical Biochemistry 2011 416 2 202 205 2-s2.0-80155147111 10.1016/j.ab.2011.05.031